Richard Paxman is the chief executive officer of Paxman Scalp Cooling, global leader in scalp cooling to prevent chemotherapy induced alopecia.
Richard studied management science at the University of Manchester Institute of Science and Technology and joined Paxman in 2008. Since then the business has had international success, and Richard is passionate about improving scalp cooling efficacy, ensuring that everyone undergoing chemotherapy treatment keeps their hair and empowering cancer patients with a choice. It is Richard’s vision to ensure that every applicable cancer patient, no matter where in the world, has the opportunity to maintain their privacy and sense of normality by keeping their hair. Richard supports investment in people, biological research, clinical trials for both regulatory and marketing reasons, plus developing innovative scalp cooling-related treatments.
Following FDA clearance of the product in 2017, Paxman scalp cooling is now available at all of the five highest-ranked cancer centers in the U.S. Successful business infrastructure including logistics, warehousing, call center, technical services, and pharmacy is in place to facilitate the growth of the business across all states in the U.S. Richard has contributed as a keynote speaker at innumerable business events around the world, ensuring the latest scalp cooling news, best practice and protocols are shared across the Paxman network and beyond.